Clinical Trial Update: Immunotherapy by Nivolumab for HIV+ Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating immunotherapy with nivolumab in HIV-positive patients with metastatic or stage IIIB non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Stage IIIB | Phase 2 | Status: COMPLETED